1: Khare P, Dave KM, Kamte YS, Manoharan MA, O'Donnell LA, Manickam DS.
Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells. AAPS
J. 2021 Dec 6;24(1):8. doi: 10.1208/s12248-021-00653-2. PMID: 34873640; PMCID:
PMC8648339.
2: Barbieri BD, Peeler DJ, Samnuan K, Day S, Hu K, Sallah HJ, Tregoning JS,
McKay PF, Shattock RJ. The role of helper lipids in optimising nanoparticle
formulations of self-amplifying RNA. J Control Release. 2024 Oct;374:280-292.
doi: 10.1016/j.jconrel.2024.08.016. Epub 2024 Aug 21. PMID: 39142355.
3: Kauffman KJ, Dorkin JR, Yang JH, Heartlein MW, DeRosa F, Mir FF, Fenton OS,
Anderson DG. Optimization of Lipid Nanoparticle Formulations for mRNA Delivery
in Vivo with Fractional Factorial and Definitive Screening Designs. Nano Lett.
2015 Nov 11;15(11):7300-6. doi: 10.1021/acs.nanolett.5b02497. Epub 2015 Oct 20.
PMID: 26469188.
4: Meulewaeter S, Aernout I, Deprez J, Engelen Y, De Velder M, Franceschini L,
Breckpot K, Van Calenbergh S, Asselman C, Boucher K, Impens F, De Smedt SC,
Verbeke R, Lentacker I. Alpha-galactosylceramide improves the potency of mRNA
LNP vaccines against cancer and intracellular bacteria. J Control Release. 2024
Jun;370:379-391. doi: 10.1016/j.jconrel.2024.04.052. Epub 2024 May 4. PMID:
38697317.
5: Borrajo ML, Quijano A, Lapuhs P, Rodriguez-Perez AI, Anthiya S, Labandeira-
Garcia JL, Valenzuela R, Alonso MJ. Ionizable nanoemulsions for RNA delivery
into the central nervous system - importance of diffusivity. J Control Release.
2024 Aug;372:295-303. doi: 10.1016/j.jconrel.2024.06.051. Epub 2024 Jun 24.
PMID: 38909703.
6: Mrksich K, Padilla MS, Joseph RA, Han EL, Kim D, Palanki R, Xu J, Mitchell
MJ. Influence of ionizable lipid tail length on lipid nanoparticle delivery of
mRNA of varying length. J Biomed Mater Res A. 2024 Sep;112(9):1494-1505. doi:
10.1002/jbm.a.37705. Epub 2024 Mar 15. PMID: 38487970; PMCID: PMC11239295.
7: Oza D, Ivich F, Pace J, Yu M, Niedre M, Amiji M. Lipid nanoparticle
encapsulated large peritoneal macrophages migrate to the lungs via the systemic
circulation in a model of clodronate-mediated lung-resident macrophage
depletion. Theranostics. 2024 Apr 8;14(6):2526-2543. doi: 10.7150/thno.91062.
PMID: 38646640; PMCID: PMC11024852.
8: Melamed JR, Hajj KA, Chaudhary N, Strelkova D, Arral ML, Pardi N, Alameh MG,
Miller JB, Farbiak L, Siegwart DJ, Weissman D, Whitehead KA. Lipid nanoparticle
chemistry determines how nucleoside base modifications alter mRNA delivery. J
Control Release. 2022 Jan;341:206-214. doi: 10.1016/j.jconrel.2021.11.022. Epub
2021 Nov 18. PMID: 34801660; PMCID: PMC8905090.
9: Borrajo ML, Lou G, Anthiya S, Lapuhs P, Álvarez DM, Tobío A, Loza MI, Vidal
A, Alonso MJ. Nanoemulsions and nanocapsules as carriers for the development of
intranasal mRNA vaccines. Drug Deliv Transl Res. 2024 Aug;14(8):2046-2061. doi:
10.1007/s13346-024-01635-5. Epub 2024 May 29. PMID: 38811465; PMCID:
PMC11208213.
10: Da Silva Sanchez AJ, Zhao K, Huayamares SG, Hatit MZC, Lokugamage MP,
Loughrey D, Dobrowolski C, Wang S, Kim H, Paunovska K, Kuzminich Y, Dahlman JE.
Substituting racemic ionizable lipids with stereopure ionizable lipids can
increase mRNA delivery. J Control Release. 2023 Jan;353:270-277. doi:
10.1016/j.jconrel.2022.11.037. Epub 2022 Nov 30. PMID: 36423872; PMCID:
PMC9897220.
11: Hajj KA, Melamed JR, Chaudhary N, Lamson NG, Ball RL, Yerneni SS, Whitehead
KA. A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery
and Gene Editing In Vivo. Nano Lett. 2020 Jul 8;20(7):5167-5175. doi:
10.1021/acs.nanolett.0c00596. Epub 2020 Jun 9. PMID: 32496069; PMCID:
PMC7781386.